Peptides

Dual GIP/GLP-1 Receptor Agonist Tirzepatide - CAS 2023788-19-2

Item No.: 2023788-19-2
Tirzepatide, a new injectable weight loss medication, is a GIP-GLP1 receptor agonist.
It has been demonstrated to significantly reduce weight in persons with type 2 diabetes, and a recent study demonstrates that it is also highly effective for those without the disease.
Description Product List Our Service and Policy Order Procedure Review
Description

GIP/GLP-1 Tirzepatide Peptide | Tripeptide Power for Enhanced Health

Inno's GIP/GLP-1 Tirzepatide peptide, identified by CAS number 2023788-19-2, is a cutting-edge tripeptide designed to support weight management and overall health. This advanced peptide combines the benefits of GIP and GLP-1, offering a comprehensive approach to metabolic balance and energy regulation.

Why Choose Tirzepatide Power?

The power of tripeptides is evident in the unique formulation of our Tirzepatide peptide. It activates key pathways for glucose control and appetite regulation, making it a potent solution for individuals seeking enhanced metabolic health. Whether you're in the USA or UK, Inno ensures prompt delivery of this high-quality peptide from our local warehouses.

Product Name Tirzepatide Alias LY3298176
CAS 2023788-19-2 Appearance Lyophilized Powder
MF C21H32N2O Typical use Weight loss peptides
Purity 98% HPLC Shelf Life 2 years


Gip\GLP-1 Tirzepatide CAS 2023788-19-2 USA/UK Warehouse LY3298176

Revolutionary Weight Loss and Diabetes Treatment

Tirzepatide, an advanced injectable medication, acts as a dual GIP/GLP-1 receptor agonist. It significantly reduces weight and improves glycemic control in individuals with type 2 diabetes and those without the condition. This innovative peptide is gaining recognition for its efficacy and convenience.

Product Specifications and Usage

CAS Number: 2023788-19-2

Appearance: Lyophilized Powder

Molecular Formula: C21H32N2O

Purity: 98% HPLC

Shelf Life: 2 years

Clinical Benefits and Applications

Tirzepatide offers a novel approach to managing type 2 diabetes and obesity. Its dual action on GIP and GLP-1 receptors enhances its ability to regulate blood sugar levels and promote weight loss. Clinical trials have demonstrated significant reductions in glycated hemoglobin and body weight, making it a preferred choice for patients and healthcare providers.

Research and Development

Recent studies, including the SURPASS-2 trial, highlight Tirzepatide's superiority over other treatments like semaglutide. Patients using Tirzepatide have shown improved outcomes in glycemic control and weight reduction, confirming its potential as a groundbreaking therapeutic option.



Tirzepatide is a novel, once-weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment of type 2 diabetes (T2D) and obesity.

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide-GLP-1 receptor agonist. Its structure is primarily based on the glucose-dependent insulinotropic polypeptide amino acid sequence and includes a C20 fatty diacid moiety. Its half-life of approximately 5 days allows once-weekly subcutaneous administration. A phase 2b trial involving patients with type 2 diabetes showed that those who received tripeptide had dose-dependent reductions in the glycated hemoglobin level and weight at 26 weeks.

Once-weekly injectable semaglutide, a selective GLP-1 receptor agonist, is approved for the treatment of type 2 diabetes at doses up to 1 mg. In trials involving patients who received semaglutide, the mean reductions in the glycated hemoglobin level have been reported to be as high as 1.8 percentage points and the mean reductions in body weight have been reported to be as high as 6.5 kg.

We conducted the SURPASS-2 trial (A Study of Tirzepatide [LY3298176] versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants with Type 2 Diabetes) to compare the efficacy and safety of tripeptide at doses of 5 mg, 10 mg, and 15 mg with those of semaglutide at a dose of 1 mg in patients with type 2 diabetes that had been inadequately controlled with metformin monotherapy.



Our Service Advantages

 

Packaging and Delivery

Packaging: Tirzepatide is securely packaged in sterile, airtight vials to ensure product integrity and stability during transit and storage.

Delivery: Orders are dispatched from our USA and UK warehouses, ensuring swift and reliable delivery. We use reputable courier services to guarantee safe and timely arrival.

 

Supply Ability

We maintain a robust inventory to meet high demand, ensuring continuous availability. Large volume orders are accommodated with consistent supply.

 

Lead Time

Standard lead time is 3-5 business days for processing and shipping. Expedited options are available upon request.


For more details, visit INNO.



Product Advantages

Dual Action Mechanism: Tirzepatide acts as a dual GIP and GLP-1 receptor agonist, enhancing its ability to regulate blood sugar levels and promote significant weight loss.

Proven Efficacy: It has shown superior results in weight reduction and glycemic control, especially for type 2 diabetes patients.

High Purity: The product is 98% HPLC-pure, ensuring high effectiveness.

Long Shelf Life: With a 2-year shelf life, it offers long-term storage stability.

Convenient Delivery: Available from USA/UK warehouses for fast shipping.



About Us - INNO Peptides

At INNO Peptides, we are dedicated to revolutionizing the fine chemicals and pharmaceutical intermediates industry. From our Wuhan headquarters, we provide high-quality cosmetic raw materials, food additives, and pharmaceutical compounds to clients worldwide. Our mission is to impact healthcare and cosmetics positively, emphasizing quality, integrity, and customer satisfaction. We offer exceptional customer service and technical support, fostering strong global partnerships. Join us on our journey of innovation and excellence.

For more information, visit our About Us page.



FAQ

Who Are We?

We are INNO Peptides, a leading provider of high-quality peptides, dedicated to innovation and customer satisfaction in the pharmaceutical and biotechnology sectors.

How Can We Guarantee Quality?

We ensure quality through rigorous testing, advanced manufacturing processes, and compliance with international standards, providing products that meet the highest industry benchmarks.

What Can You Buy From Us?

You can buy a wide range of peptides, including IGF-1 LR3, HGH, Melanotan, CJC-1295, GHRP-2, Epitalon, and more, for various research and therapeutic applications.

Why Should You Buy From Us Not From Other Suppliers?

Choose us for our commitment to quality, competitive pricing, exceptional customer service, and fast, reliable delivery from our USA and UK warehouses.

What Services Can We Provide?

We provide technical support, custom peptide synthesis, bulk ordering options, and dedicated customer service to ensure your complete satisfaction with our products.

Product List

 

No.

Product name

CAS No.

Specification

1

Sunifiram//DM-235

314728-85-3

99%min

2

Tianeptine Hemisulfate Monohydrate

1224690-84-9

98%min

3

Memantine

19982-08-2

98%min

4

Magnesium L-Threonate

78571-57-6

98%min

5

Nsi-189 Phosphate

1270138-40-3

98%min

6

Alpha GPC

28319-77-9

98%min

7

Noopept//Gvs-111

157115-85-0

98%min

8

Tianeptine Acid

66981-73-5

98%min

9

Tianeptine Sodium

30123-17-2

98%min

10

Tianeptine Sulphate

1224690-84-9

98%min

11

Pirfenidone

53179-13-8

98%min

12

Aniracetam

72432-10-1

98%min

13

Fasoracetam

110958-19-5

98%min

14

Phenylpiracetam

77472-71-0

98%min

15

Nefiracetam

77191-36-7

98%min

16

Pramiracetam

68497-62-1

98%min

17

Oxiracetam

62613-82-5

98%min

18

Galantamine

3286-46-2

98%min

19

Agomelatine

138112-76-2

98%min

20

Coluracetam//MKC-231

135463-81-9

98%min

21

HBT1//YDL223C

48948-02-8

98%min

22

Phenibut//Phenibut HCL

1078-21-3

98%min

23

N-MethyL-D-Aspartic Acid (NMDA)

6384-92-5

98%min

24

Citicoline CDP-Choline

987-78-0

98%min

25

PRL-8-53

51352-87-5

98%min

26

Nooglutyl

112193-35-8

98%min

27

IDRA-21

22503-72-6

98%min

28

Compound 7

1890208-58-8

98%min

29

Galanthamine hydrobromide

1953-4-4

98%min

Our Service and Policy

QualityControl

All products are strictly tested by our QC & QA, Approved by third party Lab.

Payment Terms

We can only accept Bank Transfer, Western Union and Money Gram and BitCoin.
Sorry for the inconvenience but Credit card or Paypal or cash on delivery is not available

Sample Policy

For some steroids like test e we can provide 10g sample. Meanwhile, you need to pay the shipping cost.

Shipping Cost

We recomanmand the package weights 100g, 500g and 1Kg due to the method of delivery.Seperate package delivery for order more than 2Kg.
General:
10g-100g: USD45
100g-500g: USD50
500g-1000g: USD55
1000g-2000g: USD60

Resend Policy

If the parcel is seized/lost/damaged and you receive seizure letter from authority, we will resend the same product for free immediately after receiving the seizure letter. We care your business plan and we will never disappoint you.

 

Order Procedure

How to Complete an Order:

Make an order

1.Please let me know the product names, quantity, and the destination country;

2.You confirm all details, and send us purchasing order;

3.We send the detail price of our product and offer the suitable shipping method;

4.You confirm the order and pay money 100% in advance and send the address.

5.We arrange the shipment according to your requirements.

6.We offer after-sales service after you receive parcel.

Shipping

Provide receiver’s addressee info

Packing

According to different countries and quantity of orders

Lead Time

Arranged within 24 hours upon receipt of your payment

Photos

Photos of parcel would be offered to tell apart the goods in advance

Delivery Time

Usually 4-6 working days to reach destinations

Tracking Number

Offered once it is released online.

After-sale Service

24/7 online for problems and concern

 

Review
Review

1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
Subscribe To Get The Latest Brochures And Quotations
Please leave your email address. We wil regularly send the latest catalog and quotation to your email.